Leukemia Research
Volume 34, Issue 1 , Pages 24-31, January 2010

In vitro secretion of matrix metalloprotease 9 is a prognostic marker in childhood acute lymphoblastic leukemia

  • Pascale Schneider

      Affiliations

    • Pediatric Hematology, Oncology and IHU, Rouen University Hospital, Rouen, France
    • Research Group MERCI (EA3829) and IHU, University of Medecin, Rouen, France
    • Corresponding Author InformationCorresponding author at: Pediatric Haematology and Oncology, Rouen University Hospital, 1, rue de Germont, 76000 Rouen, France. Tel.: +33 2 32 88 81 91; fax: +33 2 32 88 01 21.
  • ,
  • Odile Costa

      Affiliations

    • Research Group MERCI (EA3829) and IHU, University of Medecin, Rouen, France
  • ,
  • Elisabeth Legrand

      Affiliations

    • Research Group MERCI (EA3829) and IHU, University of Medecin, Rouen, France
  • ,
  • Dany Bigot

      Affiliations

    • Laboratory of Hemato-Biology, Rouen University Hospital, Rouen, France
  • ,
  • Sylviane Lecleire

      Affiliations

    • Laboratory of Hemato-Biology, Rouen University Hospital, Rouen, France
  • ,
  • Vanessa Grassi

      Affiliations

    • Department of Biostatistics, Rouen University Hospital, Rouen, France
  • ,
  • Jean-PierreVannier

      Affiliations

    • Pediatric Hematology, Oncology and IHU, Rouen University Hospital, Rouen, France
    • Research Group MERCI (EA3829) and IHU, University of Medecin, Rouen, France
  • ,
  • Marc Vasse

      Affiliations

    • Research Group MERCI (EA3829) and IHU, University of Medecin, Rouen, France
    • Laboratory of Hemato-Biology, Rouen University Hospital, Rouen, France

Received 26 January 2009; received in revised form 25 July 2009; accepted 26 July 2009. published online 07 March 2011.

Abstract 

Matrix metalloproteases (MMPs) are endopeptidases involved in tumor cell invasion. Childhood acute lymphoblastic leukemia (ALL) is characterized by its capacity to infiltrate different organs. We analyzed the expression of MMP-2, -9, -14 and TIMP-1 and -2 in a prospective study on 86 children with newly diagnosed ALL (73 B- and 13 T-lineage) and 9 children at relapse with B-ALL. Membrane-bound and intracytoplasmic MMPs and TIMPs were analyzed by flow cytometry, and secreted MMPs were quantified by ELISA. In patients at relapse, MMP-14 was present in a greater proportion of the B-ALL cell population than at diagnosis. In patients with peripheral infiltration, intracytoplasmic MMP-9 was significantly higher than in patients without infiltration. ROC curve and Kaplan–Meier curve analysis showed that a high secretion of MMP-9 (>2450pg/ml/106 cells) was associated with a lower overall survival rate, suggesting that the secretion of MMP-9 is an independent prognostic factor in childhood B-ALL.

Keywords: Childhood acute lymphoblastic leukemia, Matrix metalloprotease-9, Prognostic factor, Survival, Organ infiltration

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(09)00386-5

doi:10.1016/j.leukres.2009.07.039

Leukemia Research
Volume 34, Issue 1 , Pages 24-31, January 2010